Quantcast

Latest Contraceptive patch Stories

2014-07-17 16:26:46

Intellectual Property Portfolio Broadened for Its Proprietary Transdermal Delivery System PRINCETON, N.J., July 17, 2014 /PRNewswire/ -- Agile Therapeutics, Inc., (NASDAQ: AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that the U.S. Patent and Trademark Office issued a Notice of Allowance on July 17, 2014 for additional patent claims covering dosing regimens using...

2014-06-20 08:23:18

Expands Patent Portfolio for its Contraceptive Patch, Twirla(TM) PRINCETON, N.J., June 20, 2014 /PRNewswire/ -- Agile Therapeutics, Inc., (NASDAQ: AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that patent U.S. 8,747,888 ('888 Patent), was issued by the U.S. Patent and Trademark Office on June 10, 2014. The patent is a continuation of its prior patent US 8,246,978...

2014-06-18 08:28:27

PRINCETON, N.J., June 18, 2014 /PRNewswire/ -- Agile Therapeutics, Inc., (NASDAQ: AGRX), a women's health specialty pharmaceutical company focused on the development and commercialization of new prescription contraceptive products, today announced that Al Altomari, the Company's Chief Executive Officer and President, will participate at the Janney Capital Markets Boston Healthcare 1X1 Corporate Access Day on June 26, 2014 in Boston, MA. About Agile Agile Therapeutics is a women's...

2014-04-16 16:30:46

PITTSBURGH, April 16, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its U.S.-based subsidiary Mylan Pharmaceuticals Inc. has launched XULANE(TM) (Norelgestromin / Ethinyl Estradiol Transdermal System 150/35 mcg per day), the generic version of Janssen Pharmaceuticals Inc.'s ORTHO EVRA®* (Norelgestromin / Ethinyl Estradiol Transdermal System 150/35 mcg per day). This product is indicated for the prevention of pregnancy in women who elect to use a transdermal patch...

2014-02-13 08:31:16

Former FDA Director of the Division of Reproductive and Urologic Products/CDER, Dr. Daniel A. Shames Joins Agile Therapeutics Scientific Advisory Board PRINCETON, N.J., Feb. 13, 2014 /PRNewswire/ -- Agile Therapeutics, a specialty pharmaceutical company focused on women's health, announced today that Daniel A. Shames M.D., F.A.C.S., has joined its Scientific Advisory Board. Dr. Shames is an experienced clinician with extensive experience in pharmaceutical development and regulatory affairs....

2014-02-05 08:28:48

PRINCETON, N.J., Feb. 5, 2014 /PRNewswire/ -- Agile Therapeutics, Inc., a specialty pharmaceutical company focused on women's health, announced today that Mr. Al Altomari, President and Chief Executive Officer, will present at the 2014 Leerink Global Healthcare Conference at the Waldorf Astoria Hotel in New York on Wednesday, February 12, 2014, at 10:40 a.m. ET. About Agile Therapeutics Agile Therapeutics is a specialty pharmaceutical company focused on women's health that is...

2014-01-13 16:24:52

DUBLIN, January 13, 2014 /PRNewswire/ -- Dublin - Research and Markets ( http://www.researchandmarkets.com/research/j3nzxd/contraceptives) has announced the addition of the "Global Contraceptives Market Report 2013: Forecasts to 2018" [http://www.researchandmarkets.com/research/j3nzxd/contraceptives ] report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) The global contraceptive devices market held majority of the market share in...

2014-01-08 08:27:37

PRINCETON, N.J., Jan. 8, 2014 /PRNewswire/ -- Agile Therapeutics, Inc., announced today the appointment of Elizabeth Ijeoma Onyemelukwe Garner, M.D., M.P.H., as Chief Medical Officer effective January 6, 2014. Dr. Garner will be a member of Agile's executive management team and will lead the clinical research, drug safety and medical affairs teams in the clinical development of the Company's product pipeline. "Elizabeth has prominent expertise in women's health and significant...


Word of the Day
cacodemon
  • An evil spirit; a devil.
  • A nightmare.
  • In astrology, the twelfth house of a scheme or figure of the heavens: so called from its signifying dreadful things, such as secret enemies, great losses, imprisonment, etc.
'Cacodemon' comes from a Greek term meaning 'evil genius.'
Related